Rejuva assesses eligibility and assists patients with a history of treatment-resistant mental health afflictions make application to Health Canada for exemption under section 56(1) of the CDSA to legally access psychedelic-assisted therapy.
If it agreed that the best path forward is to proceed with an application for exemption, Rejuva’s medical professionals will facilitate the application process on behalf of the patient. Pending approval by Health Canada, Rejuva will ensure that the mental health needs of all patients continue to be addressed. This could be by providing continued one-on-one sessions, or through referral to another appropriate registered mental health professional. When and if approval for exemption is received from Health Canada, Rejuva will connect patients with therapists trained in psilocybin-assisted therapy. If patients are determined ineligible for legal access to psychedelic-assisted therapy, Rejuva will refer patients for alternative treatments.